These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17400210)

  • 21. Taxol, a microtubule stabilizer, improves cardiac contractile function during ischemia in vitro.
    Xiao J; Zhao H; Liang D; Liu Y; Zhang H; Liu Y; Li J; Peng L; Zhou Z; Chen YH
    Pharmacology; 2010; 85(5):301-10. PubMed ID: 20453554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.
    Longva KE; Pedersen NM; Haslekås C; Stang E; Madshus IH
    Int J Cancer; 2005 Sep; 116(3):359-67. PubMed ID: 15800944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart.
    Chung KY; Walker JW
    Mol Pharmacol; 2007 Jun; 71(6):1494-502. PubMed ID: 17332141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cytoprotective effect of biglycan core protein involves Toll-like receptor 4 signaling in cardiomyocytes.
    Gáspár R; Pipicz M; Hawchar F; Kovács D; Djirackor L; Görbe A; Varga ZV; Kiricsi M; Petrovski G; Gácser A; Csonka C; Csont T
    J Mol Cell Cardiol; 2016 Oct; 99():138-150. PubMed ID: 27515282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
    Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
    Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reduced myofilament responsiveness to calcium contributes to the negative force-frequency relationship in rat cardiomyocytes: role of reactive oxygen species and p-38 map kinase.
    Espejo MS; Aiello I; Sepúlveda M; Vila Petroff MG; Aiello EA; De Giusti VC
    Pflugers Arch; 2017 Dec; 469(12):1663-1673. PubMed ID: 28836001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone.
    Klos KS; Zhou X; Lee S; Zhang L; Yang W; Nagata Y; Yu D
    Cancer; 2003 Oct; 98(7):1377-85. PubMed ID: 14508823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin improves cardiomyocyte contractile function through enhancement of SERCA2a activity in simulated ischemia/reperfusion.
    Yu J; Zhang HF; Wu F; Li QX; Ma H; Guo WY; Wang HC; Gao F
    Acta Pharmacol Sin; 2006 Jul; 27(7):919-26. PubMed ID: 16787577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3β and ERK1/2 signaling pathway.
    Kim DE; Kim B; Shin HS; Kwon HJ; Park ES
    Exp Cell Res; 2014 Oct; 327(2):264-75. PubMed ID: 25128810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance.
    Huang X; Wang S; Lee CK; Yang X; Liu B
    Cancer Lett; 2011 Aug; 307(1):72-79. PubMed ID: 21497990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death.
    Singh KK; Shukla PC; Quan A; Lovren F; Pan Y; Wolfstadt JI; Gupta M; Al-Omran M; Leong-Poi H; Teoh H; Verma S
    Biochem Biophys Res Commun; 2011 Jul; 411(2):421-6. PubMed ID: 21749857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
    Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
    Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK.
    Chen YL; Loh SH; Chen JJ; Tsai CS
    Eur J Pharmacol; 2012 Apr; 680(1-3):88-94. PubMed ID: 22329895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes.
    Rude MK; Duhaney TA; Kuster GM; Judge S; Heo J; Colucci WS; Siwik DA; Sam F
    Hypertension; 2005 Sep; 46(3):555-61. PubMed ID: 16043662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overproduction of reactive oxygen species and activation of MAPKs are involved in apoptosis induced by PM2.5 in rat cardiac H9c2 cells.
    Cao J; Qin G; Shi R; Bai F; Yang G; Zhang M; Lv J
    J Appl Toxicol; 2016 Apr; 36(4):609-17. PubMed ID: 26472149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and cellular mechanisms of anthracycline cardiotoxicity.
    Chen B; Peng X; Pentassuglia L; Lim CC; Sawyer DB
    Cardiovasc Toxicol; 2007; 7(2):114-21. PubMed ID: 17652815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.